GPT and cholestasis: PTE treatments at 25, 50, and 100 mpk alleviated DDC-induced cholestasis in C7BL/6J mice, as shown by decreasing cholestasis-serum markers (AST, ALT, AP, and γ-GT) (Figure 2A).